Age and Awareness Serve to Spur the Japanese Diabetes Diagnostics Markets.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c48087) has announced the addition of Frost & Sullivan's new report: Japanese Diabetes Diagnostics Markets to their offering.

This Frost & Sullivan research service entitled Japanese Diabetes Diagnostics Markets provides a complete market analysis with Market Engineering measurements, revenue forecasts, market revenues, technology trends, market share analysis, and end-user analysis. In this research service, Frost & Sullivan's expert analysts thoroughly examine the following markets: laboratory diabetes diagnostics and POCT diabetes diagnostics.

Market Overview

Age and Awareness Serve to Spur the Japanese Diabetes Diagnostics Markets

An ageing population and a robust healthcare system are factors that drive the Japanese diabetes diagnostics market. Laboratory diabetes diagnostics has long been the "gold standard" for diabetes diagnosis, and is the largest segment, contributing to a major share of the total market. "The high awareness levels among the Japanese population about the disease have led to more number of regular health check-ups," says the analyst of this research service. Besides, the testing volumes of the non-diabetic patients undergoing diabetes diagnostic tests are high in Japan, as the entire population is covered for medical insurance. These factors have been the major contributors to market revenues in 2005.

Japan has nearly 25.0 percent of its population aged above 65 years, leading to increased number of hospitalization of patients. Moreover, with 100 percent insurance, hospitals in Japan have one of the longest average stay periods of patients of about 35 days. Thus, the longer the patients stay, higher the number of diagnostic tests done. This is one of the major factors, which had contributed to large test volumes in the point of care testing (POCT) segment and hence higher revenues.

POCT's Convenience and Quick Results to Garner Huge Market Shares

POCT is expected to take away the shares of laboratory testing. It is considered a high growth market with significant potential, and is characterized by new product launches, higher profit margins, and increasing number of market entrants. The increasing incidence of diabetes and the resulting higher volumes of diagnostic tests are bound to support this strong growth. This sort of testing is carried out predominantly during hospitalization of patients, and when quick results are required, as in a critical care unit. Quick results with comfortable ease and less pain are the main drivers for POCT applications.

"Although, only 20 percent of diabetes tests ordered through physicians are performed through the POCT approach, it is still regarded as the highest level of prescription for POCT diabetes diagnostic tests in Asia," states the analyst. Physicians preferring POCT to laboratory testing due to their proven accuracy and quality of results have certainly contributed to revenue growth in this segment. This is because a large number of physicians possess a POCT instrument for making an instant check of glucose levels in patients.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

-- Laboratory diabetes diagnostics

-- POCT diabetes diagnostics

Technologies

The following technologies are covered in this research:

-- Automation and Integration, Total lab automation

-- Non-invasive technology, centralized POCT

For more information visit http://www.researchandmarkets.com/reports/c48087